Try our Advanced Search for more refined results
Life Sciences - April, 2025
275 articles
- VSL Probiotic Buyers Win Class Cert. In RICO Case
- Wheeling & Appealing: The Latest Must-Know Appellate Action
- Nationwide Says Claim For 'Fat Freezing' Injury Isn't Covered
- Judge Keeps Pfizer Foe's COVID Vaccine Patent Case Alive
- Del. Judge Won't Let MSN Fight Entresto Orange Book Entry
- Joe Rogan-Backed 'Alpha Brain' False Ad Suit Dropped In NY
- 3rd Circ. Preview: NJ To Defend ICE Contractor Law In May
- Local Gov'ts, Union Seek Block Of COVID Grant Cancellations
- Biotech Co. Throws Flag On NFL Alumni's Bid To Toss Suit
- PTAB Axes AbbVie Unit's Cancer Drug Patent As Invalid
- Monthly Merger Review Snapshot
- Mich. AG Says Express Scripts, Prime Fix Pharmacy Rates
- Honeywell, Sourcing Co. End Scuffle Over Soured Supply Deal
- 2nd Frier Levitt Atty Joins Buchanan Ingersoll's Pharmacy Group
- Why Attys Should Get Familiar With Quantum Computing
- Kratom Cos. Get False Ad, Addiction Suit Tossed
- Adapting To Private Practice: From DOJ Enviro To Mid-Law
- Novartis Buying Regulus In Up To $1.7B Kidney Drug Deal
- Gilead Will Pay $202M In DOJ Deal Over Drug Kickbacks
- Omnicare Hit With $136M Jury Verdict For Bilking Feds
- Justices Wary Of Issuing 'Advisory' Ruling In Class Cert. Row
- DC Judge Worries About 340B Rebate Program Without 'Teeth'
- 23andMe Agrees To Privacy Ombudsman In Ch. 11
- Full Fed. Circ. Urged To Undo 'Onerous' Jepson Claim Ruling
- Fed. Circ. Backs TM Denial Of Dark Green Gloves As Generic
- GenBioPro Can Defend FDA Approval In Mifepristone Suit
- Mexico Put On Latest USTR Priority IP Watch List
- Cooley Life Sciences Ace Rejoins Latham In Bay Area
- Opioid MDL Judge Won't Recuse Over Ex Parte Allegations
- High Court Backs HHS In Hospital Pay Formula Dispute
- Chinese Cos. Lose Immunity Fight In 9th Circ. IP Case
- Veolia Settles Flint Water Crisis Claims For $53M
- Gov't Reverses Position On Surgery For Trans Prisoners
- Ziploc 'Microwave Safe' Bags Shed Microplastics, Buyer Says
- Walgreens Opposes Merging 'Non-Drowsy' Labeling Suits
- Sanofi Challenges Jurisdiction In Conn. Zantac Lawsuits
- Ala. Medical Pot Commission Sued Over Patient Registry
- Sullivan & Cromwell-Led Merck To Buy SpringWorks For $3.9B
- HHS Says Cuts Target Excess After Judge Seeks More Info
- SPAC Deals Are Buzzing Again Despite Tariff Turmoil
- Local Gov'ts, Union Sue Over COVID Grant Cancellations
- Judge Says FDA Can Take Ozempic Off Shortage List
- Legal Ethics Considerations For Law Firm Pro Bono Deals
- J&J Unit Sees Claims Trimmed In Engineer's Bias Suit
- Aggressive USPTO Policy Push Suggests 'It's Lutnick's Show'
- Ozempic Maker Settles Infringement Claims With Atlanta Clinic
- Insulet's $452M Trade Secrets Award Reduced To $59.4M
- 11th Circ. Backs FDA In Denial Of Bidi's Vape Application
- Reproductive Health Under Trump So Far, And What's Next
- Playing Football Made Me A Better Lawyer
- Circuit-By-Circuit Guide As Justices Confront Class Cert. Split
- Biz Court Questions What Ties TikTok To NC In Addiction Case
- DOJ Probing Disney-FuboTV Deal, And Other Rumors
- 10 Arbitrations And A 5th Circ. Ruling Flag Arb. Clause Risks
- Polsinelli Gains 2 Healthcare Shareholders In Denver
- Harvard Seeks To Move 'Swiftly' In $2B Fund Freeze Suit
- Keys To Handling Digital Investigations In Pharma IP Litigation
- UPS Paying $1.6B For Andlauer's Healthcare Logistics Co.
- Latham-Led LLR Clinches 7th Fund With $2.45B Committed
- 11th Circ. Considers Timeliness Of J&J Pelvic Mesh Claims
- FDA Warns Of Health Risks In Topical Hair Loss Drug
- Curaleaf Sues Ex-VP For Alleged Breach Of Noncompete
- Fed. Circ. Agrees MS Generic Drug Didn't Infringe Metacel IP
- Ex-Sprinter Turned Track Coach Cops To Olympic Doping Rap
- Law Firm Fights Sanctions Bid In Mootness Fee Row
- Ex-Exec Says Centene Harassed Him Over Void Noncompete
- Judge Lifts Biocon Eye Med Biosimilar Ban After Settlement
- Sandoz, Novartis Cut Price-Fixing Deal With South Carolina
- Genetic Testing Co., Marketer Settle FCA Case For $6M
- FCA Suit Over Allergan's Alleged Kickbacks Trimmed
- Eli Lilly Sues 4 Telehealth Cos. For Weight Loss Drug Copies
- M&A 'Pause' Requires Nimble, Creative Dealmaking
- Power To The Paralegals: The Value Of Unified State Licensing
- Swiss Drug Developer Veraxa To List In US In $1.6B SPAC Deal
- Apple Should Prevail In Heartbeat Patent Suit, Judge Says
- BlackRock Funds Drop Claims In Valeant Stock Suit
- Pharmaceutical Co. Buyers Win Del. Fraud Suit Revival
- 23andMe Has Received 'Significant Interest' In Ch. 11 Auction
- Jury Issues Mixed Verdict In Surgeon's NuVasive Patent Fight
- What's Next For Lab Test Regulation Without FDA Authority
- J&J Ends Trade Secrets Suit Against Now Deceased Ex-Exec
- Hogan Lovells Adds Ex-HHS Atty To Health Practice
- Nuclear Startup To Go Public Through $475M SPAC Deal
- MoFo Adds Perkins Coie FDA Regulatory Leader In DC
- Pain Management Co. Says Customers Pilfered Product Ideas
- Kentuckian Sues Medtronic, FDA Over Spinal Cord Stimulator
- Sun Pharma Accuses Drugstores Of $10M Refund Scheme
- Imprisoned Ex-Pharma Exec Must Pay SEC $1.8M
- Harvard Sues Trump Admin Over $2B Funding Freeze
- 10 Soft Skills Every GC Should Master
- GenapSys Fights Paul Hastings Bid To Ax Malpractice Suit
- Ozempic Maker, Texas Pharmacy Settle Knockoff Drug Claims
- Neogen Selling Cleaners Biz To Kersia For $130M
- 6 Criteria Can Help Assess Executive Branch Actions
- Justices Mull 5th Circ. Redo In ACA Preventive Care Fight
- Justices Kick Flavored-Vape Dispute Back To 5th Circ.
- Walgreens To Pay DOJ $300M Over Invalid Prescriptions
- $6.5M Deal In Amazon's PillPack TCPA Suit Gets Final OK
- Biotech Execs Seek Ch. 15 Pause Pending Trustee Removal
- Lilly Blasts Compounders' 'Scattershot' Bid To Reverse FDA
- PBMs Press 8th Circ. Bid To Pause FTC Case
- Ill. Justices To Weigh Scope Of Standard Pollution Exclusions
- An Unrestrained, Bright-Eyed View Of Legal AI's Future
- Federal Cannabis Law Reform Eyed In Bipartisan Push
- Incyte Can Get Novartis' Privileged Info On Drug Royalty Deal
- DC Circ. Has No Sympathy For Novartis Over Generic Entresto
- Solicitor General's Office Now Features Two Top Lieutenants
- Bard Plant's Emission Controls Weren't Up To Snuff, Jury Told
- Ozempic Caused Blindness, NC Woman Claims
- RI Judge Wants To Know Who's Behind $11B Health Grant Cuts
- Nestle Can't Nix Diabetics' Boost Glucose False Ad Suit
- Patent Office Plans Rulemaking For New PTAB Denial Process
- Tracking The Evolution In Litigation Finance
- Firms Seek Fee Relief Over 'Grossly Unfair' Seresto MDL Snub
- AstraZeneca Unit Hit With Antitrust Suit Over Soliris
- Keys To Regulatory Diligence In Life Sciences Transactions
- 9th Circ. Revives Defect Suit Against CR Bard Over Clot Filter
- How Courts Weigh Section 1782 Discovery For UPC Cases
- 3rd Circ. Questions Walmart's Duty To Disclose Opioid Probe
- In Vape Case, Justices Must Focus On Agencies' Results
- Zenas BioPharma Faces Investor Suit Over Post-IPO Plunge
- Cooley Boosts Life Sciences Team With Latham Partner Hire
- Calif. Court Says Co.'s Heart Monitors Are Not Tax-Exempt
- Moderna Says New Drug Plant Riddled With Defects, Mold
- UK Litigation Roundup: Here's What You Missed In London
- Haynes Boone Atty Joins Mintz Capital Markets Team
- Volunteer Firefighting Makes Me A Better Lawyer
- 11th Circ. Revives FCA Claim Against Fla. Medical Suppliers
- Bard Sickened Ga. Man With Medical Gas Pollution, Jury Told
- Geron Shareholder Sues Execs Over Drug Launch Claims
- Wyo. Justices Skeptical Of State Abortion Bans' Legality
- Sterlington Adds Ex-Loeb & Loeb PTAB Trials Head In Calif.
- Biotech Glycomine Closes $115M Series C Funding Round
- California Challenges Trump's Economic Emergency Tariffs
- Astellas Bladder Drug Patent Survives Following Bench Trial
- Biogen, Genentech Head To June Trial Over MS Drug Royalties
- Novo Nordisk Seeks Toss Of Hospital's Insulin Pen Suit
- Fed. Circ. Won't Revive Stryker Unit's Antiseptic Patents
- 39 AGs Urge Congress To Ban PBM Pharmacy Ownership
- Ga. Woman Says Baby 'Ripped Away' After Embryo Mix-Up
- Research Co. Inks $7.15M Deal To End Stock Plan Suit
- Haleon Paying $221M For Full Control Of Chinese Pharma JV
- Kirkland-Led Linden Wraps $5.4B Healthcare-Focused Fund
- E-Discovery Quarterly: The Perils Of Digital Data Protocols
- Musk Supports Deleting IP Law, Attorneys Say Let's Not
- Fed. Circ. Hears Teva Challenge To J&J Schizophrenia Drug
- Juul Seeks Ax of Noncompliant Plaintiffs In E-Cig Suits
- Ozempic Pretender On Sale In Conn., Novo Nordisk Says
- J&J Units Beat Patent Suit Over Surgical Screw Designs
- Women's Healthtech Co. Chiaro Files Ch. 15 In Delaware
- Defense Strategies After Justices' Personal Injury RICO Ruling
- Takeda Gets Actos Case Paused For Class Cert. Review
- Sandoz Sues Amgen Over Enbrel Biosimilar
- 3 Ex-Cooley IP Attys Help Launch New Fenwick Boston Office
- Law School's Missed Lessons: Preparing For Corporate Work
- Amgen Can't Ditch Regeneron's Bundling Antitrust Suit
- Express Scripts Judge Asks If Khan's FTC Exit Affects Suit
- Dentsply Brass Face Investor Suit Over Alleged Dental Injuries
- Tariff Reprieve Offers Little Comfort For Venture-Backed IPOs
- Aurinia Sues Lotus Alleging Lupus Drug Patent Infringement
- Telehealth Co. Sued Over 2024 Data Breach
- AbbVie, Sandoz Settle Patent Fight Over Rinvoq Generics
- Philly Dispensary's $24.5M Award Upheld In Fraud Suit
- 7th Circ. Asks For Ill. Justices' Input On Pollution Exclusion
- 5th Circ. Revives Unfair Competition Fight Over Arthritis Drug
- Future Pak Goes Public With $255M Theratechnologies Bid
- UK Litigation Roundup: Here's What You Missed In London
- AbbVie Wants ND, SD Drug Pricing Laws Blocked
- Ga. Rehab Facility Settles In $77.6M Wrongful Death Suit
- IP Forecast: Novartis' Entresto Fight Heads To DC Circ.
- Vanda Sues FDA To Block Off-Label Use Drug Promo Regs
- 9th Circ. Open To Sending Invisalign Antitrust Suit To Trial
- Pharma Giants Sued Over Ex-Sanofi Drug Delivery Patents
- ITC Blocks Imports Of Copycats Of Eli Lilly Weight Loss Drug
- Pa. Family Blames Fatal House Fire On Prosthetic Arm Battery
- Pharma Cos.' Patent Practices Limit Drug Access, Report Says
- 3 Red Flags To Watch For When Valuing Patent Portfolios
- Holmes Seeks Full 9th Circ. Review Of Theranos Fraud Appeal
- 3rd Circ. Backs Hospital In Doctor's COVID Vaccine Bias Suit
- How Cos. Can Mitigate Increasing Microplastics Liability Risk
- A Cold War-Era History Lesson On Due Process
- Purdue Cleared To Start Ch. 11 Claims Processing Early
- Kroger Customers Get Certification In Prescription Billing Suit
- Improv Makes Me A Better Lawyer
- Device Co. Suggested 'Crazy Glue' To Fix Fatal Flaw, Suit Says
- Tillis Says China IP Theft Should Be Priority In Trade Talks
- 'You Won,' Fed. Circ. Judge Tells Drug Co. Fighting Injunction
- Mich. Panel: Gilead Immune From Recalled COVID Drug Suit
- Full Fed. Circ. Lets Stand Patent Tied To $400M Labcorp Loss
- 9th Circ. Won't Restore Competing TM Claims In Vitamin Row
- Bristol Myers Beats Pomalyst Antitrust Suit Alleging IP Fraud
- Ga. Hospital Faces Suit Over Toddler's Death From Ant Bites
- FDA: Pharmacies' Bid To Keep Making Eli Lilly Drug Is 'Absurd'
- 2nd Circ. Allows Takeda To Appeal Actos Antitrust Class Cert.
- White & Case-Led EQT Inks Nearly $3B Health Deal With KKR
- How BigLaw Executive Orders May Affect Smaller Firms
- FDA Slow To Act On Hemp And Vapes, Congress Hears
- Ex-Client Wants $1M Cut From McCarter & English Fee Win
- Religious Mission Justifies Philly Injection Site, 3rd Circ. Told
- New Mexico 3rd State To Legalize Psilocybin Therapy
- Pillsbury Expands Houston Office With 3 Corporate Attys
- Lawsuits Shouldn't Be Shadow Assets For Foreign Capital
- Jazz Agrees To Pay $145M To Settle Xyrem Antitrust Fight
- Expert And 'Worthlessness Theory' Ejected In Valsartan MDL
- Medicare Drug Price Plan Tramples Constitution, 3rd Circ. Told
- Fed. Circ. Considers Sandoz's Bid To Undo $39M Patent Loss
- Pacira Reaches IP Deal Allowing Generic Painkiller In 2030
- Judge Preserves Psilocybin Trade Secrets Theft Suit
- How To Accelerate Your Post-Attorney Career Transition
- 5 Key Licensing Considerations For AI Innovations
- Fed. Circ. Affirms Alkem's Generic Antibiotic Not Barred By IP
- Bernstein Litowitz, Kessler Topaz Seek To Lead GSK Investors
- Longtime Cooley Life Sciences Ace Jumps To Wilson Sonsini
- Ruling Adds To Risk Of Patent Format Tied To Improvements
- Torrent Seeks Arbitration In Drug Commercialization Fight
- Policy Group Tells 4th Circ. Drug Discount Law Needs Reform
- Birth Control Companies Escape Conn. Long-Arm Injury Suits
- Drug Buyers, Generics Cos. Fight Over Bellwether Litigation
- Incyte Can't Get Pretrial Win In Novartis Royalty Fight
- A Higher Bar For Expert Witnesses In Drug Patent Litigation
- AGs Announce $335M Opioid Deal With Mylan
- Monthly Merger Review Snapshot
- Compensation Up For Quest Diagnostics GC After Earlier Dip
- Law School's Missed Lessons: Be An Indispensable Associate
- AbbVie Says Aurobindo's Rinvoq Generic Infringes Patent
- Fed. Circ. Backs Ruling Against Parents In Vaccine Case
- NIH Wants Prompt 1st Circ. Review Of Agency's Grant Caps
- Azzur Creditors Call $61M DIP Rollup Excessive
- Radius Health Stockholders Sue Ex-CEO After $890M Co. Sale
- 2nd Circ. Won't Revisit Benefit Math In Colgate ERISA Suit
- Mich. Justices Order More Arguments In Lilly Insulin Case
- Masimo Shareholder Vote Suit Against Founder Moved To Calif.
- GSK Inks $67M Deal To Resolve Zantac Cancer Risk FCA Suit
- FTC Chair Seeks to Revive Insulin Case By Ending Recusal
- Taxation With Representation: Ropes & Gray, Paul Hastings
- Birding Makes Me A Better Lawyer
- AGs Sue To Halt Disruptions To NIH Grant Funding
- Optum, Express Scripts Want Judge Ousted From Opioid MDL
- GSK, Pfizer Agree To End Patent Fight Over RSV Vaccines
- International Disputes And Trade Lawyer Heads To Foley Hoag
- AI Dominated Venture Funding In Q1 As Broader Market Lags
- Compounders Say Shortage Of Weight Loss Drug Continues
- Senate Panel Advances Bills Tackling Drug Patents, Pricing
- 2nd Circ. Judge Thinks Drug Price Fight Sounds Like Antitrust
- Nestlé, Other Parent Cos. Freed From Baby Food Metals MDL
- Amazon, Biotech Net $1.9M Win Against Fake Supplement Sellers
- Texas Appeals Court Backs UT Royalty Award In Pet Co. Suit
- RI Judge Hits Pause On Billions In Health Grant Funding Cuts
- Justices' Ruling Empowers FDA To Rein In Vapes, Experts Say
- $10M Heritage Pharma Price-Fixing Deal Gets Final OK
- 5 Fed. Circ. Clashes To Watch This Month
- NIH Sued By Researchers Over 'Ideological Purge' On Grants
- With Dems Fired, GOP Recused, FTC Pauses PBMs Case
- PE Firm TPG Wants Endo Trust's Transfer Suit Tossed
- Zoll Gets Parts Of Data Breach Class Action Tossed
- MSN Denied More Relief For 'Falling Sky' In Entresto Dispute
- Garmin Beats Fitness Tracker Patent Suit, For Now
- CVS Asserts DOJ's Opioid Prescription Suit Lacks Facts
- Bidi Vapor Says FDA Denial Of E-Cig Was Unlawful
- Orthodontic Software Co. Hit With Data Breach Class Action
- Adapting To Private Practice: From DOJ Leadership To BigLaw
- Justices Broaden RICO Reach To Personal Injuries
- Supreme Court Backs FDA Block Of Flavored Vapes
- FDA Beats Challenge To Approval Of Elanco's Cattle Gas Drug
- Takeda Antitrust Trial Over Actos Generics Set For July
- Fla. Defends Sandoz Price-Fixing Settlement Terms
- Two More Pharmacies Hit With Eli Lilly Weight Loss Drug Suits
- No Inequitable Conduct From Fresenius Foe, Judge Says
- Fed. Circ. Ruling Reaffirms Listing Elements Separately Is Key
- Ex-Biotech CEO Wrongly Sentenced To 7 Years, DC Circ. Told
- IBM And J&J Beat 'Speculative' Data Breach Suit, For Now
- Talc Claimants Tell 3rd Circ. Whittaker Couldn't File Ch. 11
- FDA Cuts Prompt Biotech Players To Rethink Deal Strategies
- State Extended Producer Responsibility Laws: Tips For Cos.
- Law Firm Executive Orders Create A Legal Ethics Minefield